Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
transOMIC Technologies
Huntsville, Alabama, United Stateshudsonalpha.org ↗
- Ownership
- Private
- Employees
- ~15
- Development stage
- Commercial
01
Overview
transOMIC Technologies was a leading provider of next-generation genomic modulation and gene editing tools—including CRISPR/Cas9 reagents, RNAi resources, cDNAs/ORFs, and lentiviral vectors—to support life science researchers in unraveling genetic complexity and advancing disease understanding. The company specialized in custom vector construction for major pharmaceutical partners but ceased operations as of January 1, 2024.
- Modalities
- CRISPR-based therapy (research tools, not therapeutics)RNA interference (RNAi)Gene expression tools
- Industry
- Non-Drug Biotech
02
Partnerships
IMUNON (formerly Celsion): strategic investment/partnership for DNA vaccine vector design servicesERS Genomics Limited—CRISPR/Cas9 licensing agreement to commercialize products using foundational patents
Beyond the preview
Go deeper on transOMIC Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on transOMIC Technologies.